№ files_lp_3_process_9_60110
File format: docx
Character count: 1554
File size: 19 KB
Administrative healthcare transfer record documenting patient identification, clinical history, implant specifications, and required reports for continuity of cochlear implant care between CI centres within the NHS.
Document Type:
Patient transfer form
Subject:
Transfer of cochlear implant care between centres
Healthcare Sector:
National Health Service (NHS)
Confidentiality:
Private and Confidential
Patient Category:
Cochlear implant recipient
Institutions Involved:
Referring CI centre and receiving CI centre
Required Attachments:
Annual review reports; pre-implant assessment reports; mapping or programming summaries; programming software export via secure email; post-operative X-ray
Patient Information Fields:
Name; Date of Birth; Address; NHS Number; Contact telephone numbers; Email; Languages spoken; Interpreter requirements; Carer names; GP details; Overseas patient status
Clinical Information Fields:
Date of implant surgery; Date of switch on; Date of last programming; Date of last processor upgrade; Implant make and model; Implant serial number; Sound processor make and model; Processor serial number; Processor colour; Coil/Cable length; Magnet strength; Medical complications; Aetiology; Speech perception outcomes
Geographical Scope:
United Kingdom
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2020
Region / City:
Not specified
Topic:
Medical necessity determination, implantable hearing solution
Document type:
Pre-determination / Prior Authorization letter
Organization / Institution:
Cochlear Americas
Author:
Not specified
Target audience:
Health care providers, insurance companies
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2020
Region / city:
Not specified
Topic:
Medical necessity, Cochlear implants
Document type:
Example letter
Organization / institution:
Cochlear Limited
Author:
Not specified
Target audience:
Healthcare providers, insurance companies
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Note:
Date
Attn:
Appeal department
Year:
2020
Region / City:
United States
Topic:
Health Care, Pediatric Cochlear Implants
Document Type:
Appeal Letter
Organization / Institution:
Health Plan
Author:
Physician
Target Audience:
Health Insurance Providers, Medical Professionals
Period of Validity:
Ongoing
Approval Date:
March 17, 2020
Date of Changes:
N/A
Year:
2008–2025
Population:
Postlingually deafened adult CI listeners and typical hearing controls
Sample size:
8–477 participants per study
Mean age at CI implantation:
47–62.5 years
Mean duration of CI experience:
1.83–9.69 years
Type of document:
Research summary table
Measurements:
Psychophysical tuning curves, spectral-temporally modulated ripple tests, consonant/vowel categorization, spectral modulation detection
Speech perception tests:
CNC word recognition, AzBio sentence recognition, K-CID, K-HINT, IEEE sentences, vowel/consonant identification
Main findings:
Correlations between spectral resolution measures and various speech recognition outcomes, ranging from non-significant to strong (0.21–0.69)
Global vs. channel-specific measures:
Both types analyzed depending on study
Discrimination vs. categorization:
Both assessed across studies
Noise conditions:
Quiet and multi-talker babble with SNR levels from 0–20 dB
Year:
2026
Region:
United States
Topic:
Health Insurance, Hearing Implants
Document Type:
Guidance Document
Organization:
Cochlear Americas
Author:
Cochlear Professional Resources Team
Target Audience:
Healthcare providers, patients seeking implantable hearing solutions
Coverage Focus:
Cochlear Implants, Baha® Systems
Key Processes:
Pre-certification, Pre-authorization, Appeals, Predetermination
Contact Information:
OMS Phone: (800) 633-4667 option 4, Email: [email protected]
Additional Resources:
Regional Reimbursement Experts, Coding Support Line
Year:
Not specified
Country:
New Zealand
Sector:
Health and Disability Support Services
Subject:
Cochlear Implant Services for Severe and Profound Hearing Loss
Document Type:
Service Specification
Program Code:
DSSC107
Responsible Authority:
Ministry of Health
Coordinating Authority:
Ministry of Health in liaison with the Ministry of Education
Funding Programme:
Disability Support Services (DSS) and Habilitation Services
Service Scope:
Nationwide
Target Population:
Eligible Adults (19 years and over) and Eligible Children (up to 18 years) with severe or profound bilateral hearing loss
Eligibility Basis:
Health and Disability Services Eligibility Direction 2011
Key Components:
Cochlear implant assessment, surgery, audiology services, rehabilitation for adults, habilitation for children, ongoing maintenance and support, processor replacement, funded repairs and spare parts
Clinical Governance:
National Clinical Protocols approved by the Ministry
Performance Framework:
Results Based Accountability (RBA) Framework
Service Providers:
Contracted cochlear implant service providers
Exclusions:
Individuals implanted outside New Zealand public programme, ACC-funded cases, and non-residents
Note:
Year
Topic:
Audiology
Document Type:
Medical Report
Organization / Institution:
Audiology Hearing Rehabilitation Center
Target Audience:
Healthcare Professionals
Note:
Date
Year:
2014
Region / city:
United States
Topic:
Medical Device Appeal
Document type:
Letter
Organization / institution:
Cochlear Americas
Author:
Physician
Target audience:
Appeals Reviewer, Health Insurance Providers
Duration:
N/A
Approval date:
N/A
Modification date:
N/A
Contextual description:
A letter appealing the denial of benefits for a Cochlear Baha Attract System, outlining its medical necessity, technological advancements, and supporting clinical studies.
Year:
2021
Region / City:
Southampton, Nottingham, United Kingdom
Field:
Healthcare, Cochlear Implants, Telemedicine
Document type:
Research Article
Institution:
University of Southampton, University of Nottingham
Authors:
Helen Cullington, Padraig Kitterick, Mark Weal, Magdalena Margol-Gromada
Target Audience:
Researchers, Healthcare Providers, Clinicians
Duration of Study:
6 months
Date of Approval:
2021
Date of Last Update:
2021
Year:
2020
Region / City:
Not specified
Topic:
Medical necessity determination, implantable hearing solution
Document type:
Pre-determination / Prior Authorization letter
Organization / Institution:
Cochlear Americas
Author:
Not specified
Target audience:
Health care providers, insurance companies
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2023
Region / city:
Ireland
Topic:
Healthcare, Medical Devices, Adverse Incidents
Document type:
Guide
Author:
Health Products Regulatory Authority (HPRA)
Target audience:
Healthcare Professionals, National Mesh Administrators
Date of approval:
2023
Date of changes:
N/A
Year:
2022
Region / City:
United Kingdom
Subject:
MRI safety of non-coronary vascular stents
Document Type:
Policy
Organization:
MRI Safety, Frank Shellock
Target Audience:
Medical professionals, researchers, and MRI safety experts
Validity Period:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Keywords:
MRI, vascular stents, safety, non-coronary, RF heating, projectile effect, SAR limits, implant risks
Note:
Date
Attn:
Appeal department
Year:
2023
Author:
Lynn Pencek, RDH, MS
Type of Document:
Reference compilation / Educational resource
Topic:
Dental hygiene, implant maintenance
Intended Audience:
Dental hygienists and clinicians
Date of Publication:
June 10, 2023
Source Type:
Journal articles, clinical guidelines, online resources
Geographic Focus:
International
Note:
Year
Author:
Dr. Sheibani Nia
Year:
2022
Region / City:
Boston, MA, USA; Rio de Janeiro, Brazil; Providence, RI, USA
Topic:
Dental implants, occlusal contact, pressure-sensitive indicators
Document type:
Clinical study
Institution / Organization:
Harvard School of Dental Medicine, University of The State of Rio de Janeiro, Johnson and Wales University
Author:
Philip Millstein, Carlos E. Sabrosa, Wai Yung
Target audience:
Dental professionals, researchers in restorative dentistry
Period of validity:
Not specified
Approval date:
December 08, 2022
Date of changes:
Not specified
Organisation:
Canberra Health Services
Department:
Radiation Oncology Department
Document Type:
Clinical Procedure
Clinical Focus:
Prostate Fiducial Marker Implant
Patient Group:
Adult patients
Professional Scope:
Registered Nurses (RNs)
Standards Referenced:
Australian College of Perioperative Nurses (ACORN) Standards
Related Facility:
Canberra Hospital
Procedure Context:
Radiation therapy preparation
Setting:
Brachytherapy bunker theatre
Procedure Code:
CPT 51715
Procedure Name:
Endoscopic injection of implant material into the submucosal tissues of the urethra and/or bladder neck
Clinical Indication:
Stress urinary incontinence in women
Population:
Women with stress urinary incontinence
Evidence Sources:
Cochrane Review (Kirchin 2012); NICE 2005; NICE 2019; American Urology Association 2017; Syan 2016; MODA 2019; Aetna 2019
Study Types Referenced:
Randomized controlled trials; case series; systematic review; guideline statements
Comparators:
Conservative treatment; placebo injection; surgical management; pelvic floor muscle training
Reported Outcomes:
Continence rates; quality of life; patient satisfaction; adverse events; objective cure
Adverse Events Reported:
Urinary tract infection; urinary retention; dysuria; abscess; urgency of micturition; prolonged pain; haemorrhage; migration of bulking agent; allergic reaction
Regulatory Reference:
FDA-cleared bulking agents listed (Coaptite, Contigen, Durasphere, Macroplastique, Uryx)
Coverage Criteria:
Prior conservative management; defined duration of symptoms; documented improvement after initial treatments; limitation on number of injections
Guideline Recommendations:
Consider in patients unsuitable for or declining surgery; counseling on limited long-term efficacy and potential need for repeat injections
Review Date Mentioned:
August 2019